This study first reveals the molecular mechanism by which the (P)RR/ERK/PPARγ pathway participates in the development of hypertension combined with MAFLD, providing support for the development of future therapeutic drugs for hypertension combined with MAFLD. The gene discussed is MAPK1; the disease is hypertensive disorder.